This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Invectys Sa, Invectys. Active years: 2018-2025.
Location History:
- Le Vesinet, FR (2018 - 2021)
- Le Vésinet, FR (2021 - 2023)
Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Julien Caumartin
Introduction
Julien Caumartin is a notable inventor based in Le Vésinet, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 8 patents, Caumartin's work focuses on advancing therapeutic approaches against specific human leukocyte antigens.
Latest Patents
Among his latest patents, Caumartin has developed chimeric antigen receptors (CAR) that target multiple isoforms of human leukocyte antigen-G (HLA-G). This invention specifically addresses CARs that are effective against both β2M-free and β2M-associated immunosuppressive isoforms. Additionally, he has created anti-HLA-G specific antibodies, which are directed against the HLA-G protein. These antibodies are raised against an immunogenic peptide derived from the α3 domain of the HLA-G protein, showcasing his innovative approach to immunotherapy.
Career Highlights
Throughout his career, Julien Caumartin has worked with various companies, including Invectys and Invectys Sa. His work in these organizations has allowed him to further develop his research and contribute to advancements in the field of immunology.
Collaborations
Caumartin has collaborated with notable colleagues such as Maria Loustau and Pierre Langlade Demoyen. These partnerships have likely enriched his research and contributed to the success of his innovative projects.
Conclusion
Julien Caumartin's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic approaches against immunosuppressive conditions.